Background. We studied a cohort of human immunodeficiency virus (HIV)-infected adults in Uganda who were not receiving antiretroviral therapy, to explore the impact of helminths on HIV progression in areas where antiretrovirals are not available.
Laboratory evidence has demonstrated that helminths have a potent effect on the immune system and may have an important influence on other infections. Much interest has been generated with respect to the type 1/type 2 paradigm. Th1 lymphocytes secrete interferon-g and interleukin (IL)-2 and promote phagocytosis and the intracellular killing of microbes, a response that is essential for effective immunity against viral infection. Large eukaryotic pathogens, however, especially helminths, tend to induce a type 2 immune response, which is characterized by B cell proliferation, antibody production, and eosinophil production and is mediated by Th2 cells, which secrete IL-4, IL-5, IL-10, and IL-13. It is of importance that there is evidence from animal models and human studies indicating that helminth infection impairs the type 1 response not only to helminths but also to unrelated antigens; in some cases, this effect is reversible with antihelminthic treatment [5] [6] [7] [8] [9] [10] [11] .
There are, however, complex factors beyond a simple type 1/type 2 dichotomy, such as the suppressive ac-tivities of regulatory T cells and the direct effects of certain cytokines on HIV transcription, which may influence viral replication and immune dysfunction as HIV progresses to AIDS [12] [13] [14] [15] [16] .
There is debate about HIV disease progression in Africa. Data from early during the HIV pandemic suggested that HIV disease progressed faster in patients in Africa [17] . There have been, however, few good studies, and the best so far suggested surprisingly little difference, compared with rates of progression in developed countries [18] .
Before we can say with confidence that chronic helminth infection is deleterious to the immune response to HIV or that this effect is reversible with treatment, it behooves us to study these parameters, for a range of helminth infections, in adequately sized cohorts. We have studied the effect of helminth infection and treatment on CD4 + cell count, viral load, and mortality in a large cohort of HIV-infected adults in Uganda.
PATIENTS, MATERIALS, AND METHODS
Clinical and field methods. Study subjects, who attend either the AIDS Support Organisation clinic or the Uganda Virus Research Institute clinic in Entebbe, were members of the Entebbe Cohort (EC). This prospective cohort of HIV-infected adults was established by the UK Medical Research Council (MRC) in 1995 [19] , and recruitment to the cohort is ongoing; participants (∼700) attend routinely every 6 months, where blood is taken for CD4 + T lymphocyte measurements and other data are collected. On recruitment to the present study, these retrospective data were available. Although some participants were recruited to the EC and to the present study at the same visit, the existing prospective cohort allowed us to look retrospectively, for the majority of subjects, at the decrease in CD4 + cell count. We assumed that subjects diagnosed as having helminths at enrollment into the current study had had helminth infection during the preceding 6-month period. Ethical approval for the study was obtained from the Uganda National Council for Science and Technology, the ethics committee of the Uganda Virus Research Institute, and the ethics committee of the London School of Hygiene and Tropical Medicine.
All patients attending their routine EC appointment were counseled and recruited into the present study after they provided written, informed consent. A questionnaire was completed; stool, urine, and blood samples were collected; and albendazole (400 mg) was provided (as directly observed treatment) to all subjects. Subjects returned after 1 month, and those identified from their enrollment specimens as having Schistosoma mansoni infection were treated with praziquantel (40 mg/kg, directly observed). All subjects were seen at their subsequent (6-monthly) routine EC appointment, when a follow-up questionnaire was completed and stool and blood samples were collected. Subjects who missed their follow-up appointments were traced at their homes by field-workers and encouraged to visit the clinic. Subjects with Strongyloides stercoralis infection were contacted and treated with albendazole (400 mg 2 times/day for 3 days). Where helminth infection was detected in follow-up specimens, subjects were contacted by a field-worker and treated as appropriate.
Laboratory tests. Duplicate 41.7-mg Kato-Katz smears [20] , modified formol-ether concentrations, and charcoal cultures for Strongyloides species were performed on all fecal specimens, where possible. The microbiology laboratory at MRC subscribes to the College of American Pathologists Parasitology Surveys Program and achieves consistently good results. In addition, the first 500 duplicate Kato smears were read independently by the Vector Control Division of the Ugandan Ministry of Health; results were consistent except at the lowest limit of detection, where samples contained !12 eggs/g (i.e., 1 egg/stool sample).
ELISA for circulating anodic antigen (CAA) of Schistosoma mansoni [21] was performed on serum samples, to boost the limited diagnostic yield of a single stool sample and also to avoid the confounding effect of immunosuppression on fecal egg excretion [22] . This assay was performed on samples from all subjects at the time of enrollment; at 6 months, it was performed on samples from all subjects who had Schistosoma mansoni at the time of enrollment and negative Kato smears at follow-up. CAA ELISAs were not performed at follow-up on samples from subjects initially free of Schistosoma mansoni infection, because very few (9) new infections were detected by Kato smear. These techniques have been described in detail elsewhere [23] .
Infection with microfilaria was diagnosed by use of a modified Knott's concentration method described for patients with hyperproteinemia [24] . In brief, 1 mL of whole blood was added to 9 mL of 2% Triton X and left to stand for at least 30 min, then centrifuged at 120 g for 5 min. After pipetting off the supernatant, 100 mL of 1% formalin was added to the deposit, which was examined in its entirety for microfilaria. Positive slides were stained with Leishman's stain to assess morphology. This technique was performed on samples from all subjects at the time of enrollment and, for those that tested positive, after 6 months of follow-up. Of samples that tested negative at enrollment, 1 in 7 were randomly rescreened at the time of followup; only 1 infection was identified, which suggests that few infections were missed by this screening protocol. No treatment was offered for microfilarial infection.
In addition, a rapid immunochromatographic test for Wuchereria bancrofti antigen, by use of kits donated by Amrad, was performed on blood from 50 consecutive subjects; urine filtration for Schistosoma haematobium, by use of kits (Vestergaard Frandsen) donated by the World Health Organization (WHO), was performed on 10-mL urine samples from 123 consecutive Plasma was stored at Ϫ80ЊC for HIV-1 RNA quantification, which was determined by Bayer Versant branched DNA assay (version 3.0; Bayer). Then, 250-mL plasma samples were assayed, giving a detectable range of 200-2,000,000 copies/mL. Samples from 3 subjects were below the detectable range and were classified as having 100 copies/mL (2 log) for the purposes of analysis. Samples from 5 subjects were above the detectable range and were classified as having 2,000,000 copies/mL (6.3 log) for the purposes of analysis.
Statistical analysis. Sample-size calculations were based on a pilot study in the same cohort that revealed a helminth prevalence of ∼30% [25] . Analysis of 500 subjects was calculated to have at least 90% power to detect a difference in mean CD4 + cell count of ∼100 cells/mm 3 as significant at the 5% level (under the assumption that the SD of the CD4 + cell count is equal to the mean), at least 85% power to detect just under a 2-fold difference in mean decrease in CD4 + cell count as significant at the 5% level (under the assumption that the SD of CD4 + cell count decrease is about twice the mean), and at least 80% power to detect a difference of 0.5 log 10 viral load as significant at the 5% level. Study data were entered into Foxpro for Windows (version 2.6; Microsoft) and analyzed by use of STATA (version 6.0; STATA). Comparisons of the median CD4 + T lymphocyte count and median absolute eosinophil count were made by Wilcoxon paired and unpaired tests and of decreases in the mean CD4 + cell count and mean log 10 viral load by Student's paired and unpaired t tests, where appropriate. Analyses of association were made by use of standard tables. CD4 + cell counts in this 2 ϫ 2 cohort were skewed and did not approach a normal distribution, even after log transformation. For this reason, they were categorized as a binary variable; crude and adjusted odds ratios for CD4 + cell counts !200 cells/mm 3 were estimated by logistic regression. Adjusted mean log 10 viral loads (which were normally distributed) were estimated by linear regression. Crude and adjusted hazard ratios for mortality during 6 or 12 months (22) 97 (33) .005 21 (18) .004 72 (42) !.001
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RESULTS
A total of 663 subjects were enrolled into the study between February 2001 and March 2002. The study profile is displayed in figure 1 . The 82 subjects excluded from the analysis because of insufficient samples for parasitological diagnosis included 6 subjects who were unable to provide a stool sample, 14 who provided enough stool only for a Kato-Katz smear, 5 for whom blood was not tested for Mansonella perstans infection, and 57 who did not provide enough stool specimen for charcoal culture. Because this method contributed significantly to the diagnosis of hookworm and Strongyloides species, further analysis was restricted to the 547 subjects with complete parasitological data. Excluded subjects did not differ from the remaining subjects with respect to age, sex, CD4 + cell count at the time of enrollment, or socioeconomic variables (apart from less-frequent consumption of chicken among excluded subjects;
). P p .02
Baseline Characteristics
Helminth prevalence. Overall helminth prevalence was 53.8%, with Schistosoma mansoni (31.4%), hookworm (21.9%), Strongyloides stercoralis (12.4%), and Mansonella perstans (7.5%) constituting the principal helminth species in this cohort. Trichuris trichiura (3.7%), Ascaris lumbricoides (1.1%), and Trichostrongylus species (0.5%) were also seen; 34% of subjects were infected with 11 helminth species. The relative diagnostic yield of each parasitological technique in this study has been analyzed elsewhere [23] . CD4 + T lymphocyte count, clinical stage, and HIV-1 RNA load. At the time of enrollment into the study, the overall median CD4 + cell count was 263 cells/mm 3 (interquartile range, 129-474 cells/mm 3 ). Some 38% of subjects had a CD4 + cell count !200 cells/mm 3 , and 36% were in WHO clinical stages 3 or 4.
The mean viral load was 4.83 log 10 copies/mL (SD, 0.88 log 10 copies/mL). A higher viral load was associated with a lower CD4 + cell count ( ) and more-advanced clinical stage P ! .001 ( ) (data not shown).
Factors associated with helminth status. Table 1 shows characteristics according to helminth status at the time of enrollment. Helminth infection was associated with male sex; lower socioeconomic status, as measured by absence of electricity supply at home, use of firewood as cooking fuel, and infrequent consumption of chicken (data not shown); and expected risk factors, such as occupational exposure ("high helminth exposure" was defined as farming, fishing, laboring, or being unemployed), distance from Lake Victoria, and walking barefoot in the yard. There was no association with previous antihelminthic therapy (data not shown). Baseline characteristics varied with helminth species in a predictable fashionfor example, walking in the yard barefoot was associated with hookworm but not with Schistosoma mansoni, whereas walking distance from Lake Victoria was associated with Schistosoma mansoni but not with other worms. Helminth-infected subjects were slightly more likely to provide an unformed stool sample, although only subjects with Schistosoma mansoni reported more diarrhea during the previous month than other subjects (25% vs. 17%;
). P p .03 Helminth infection was strongly associated with eosinophil count (table 1). The median absolute eosinophil count was significantly higher in those with hookworm, Schistosoma mansoni, Strongyloides stercoralis, or Mansonella perstans infection than in those without helminths.
Effect of helminths on CD4 + cell count and viral load. Overall, helminth-infected subjects had higher CD4 + cell counts than helminth-free subjects, but this was not statistically significant ( Some 409 subjects (75%) had joined the EC and so had attended at least 1 routine cohort appointment before enrollment into the current study; for these subjects, a CD4 + cell count from 6 months before enrollment was available. The mean decrease in CD4 + cell count during the 6 months prior to enrollment was similar, regardless of helminth status (table  2) . A smaller group of subjects had sufficient data to compare decreases in CD4 + cell count during the previous 12 months; again, there was no difference between those with and without worms (data not shown). In contrast, helminth infection was associated with a higher mean log viral load at the time of enrollment ( ); this approached statistical significance P p .03 when data were restricted to subjects with Schistosoma mansoni or Strongyloides stercoralis but not with hookworm or Mansonella perstans infection (table 2) .
Age and sex, as well as all variables associated ( ) with P ! .20 helminth status and with CD4 + cell count, were included in multivariate logistic regression analyses, to identify the adjusted effect of helminth infection on CD4 + cell count. Results of the final models, in which variables differed according to helminth species, are shown in table 3. Adjusting for these factors had a small effect on the crude odds ratios of helminth infection against CD4 + cell count, which remained significant only for hookworm.
Univariate analyses of baseline variables against log viral load were also performed, and factors that were identified as being associated with viral load and helminth status were studied in included distance from lake, occupation, walking in the yard barefoot, electricity supply, and stool consistency for any helminths; occupation, walking in the yard barefoot, electricity supply, and stool consistency for hookworm; distance from lake, occupation, and stool consistency for Schistosoma mansoni; occupation, walking in the yard barefoot, and stool consistency for Strongyloides stercoralis; and distance from lake, occupation, walking in the yard barefoot, and electricity supply for Mansonella perstans. b For individual helminth species, ORs are comparing those with and without that helminth species. + cell count, according to whether helminths were present or were apparently cleared by 6 months, are shown by helminth status at the time of enrollment in figure  2 . Although slightly greater decreases in CD4 + cell count were seen in helminth-infected subjects who were free of helminths at 6 months than in those in whom helminths were detected at 6 months, this only approached significance in subjects with hookworm (mean decrease, 49.5 cells/mm 3 Change in viral load after treatment. Plasma samples were unavailable for 11 of 429 subjects who provided complete follow-up data. Of the remaining 418 subjects, the mean viral load was 4.76 log 10 copies/mL at the time of enrollment and was 4.71 log 10 copies/mL at follow-up ( , paired t test). P p . 22 Changes in viral load according to infection status at followup are shown in figure 3 ; they did not differ statistically, except + cell count according to helminth status at the 6-month follow-up, by helminth species at enrollment. Follow-up helminth status applies to specific helminths (where appropriate)-that is, for hookworm, subjects were classified by hookworm status at follow-up. P values refer to Student's t test comparing the mean decrease in CD4 + cell count for cleared infection vs. persistent infection or reinfection, (i.e., infection absent vs. present at follow-up).
among Mansonella perstans-infected subjects, in whom the persistence of infection at follow-up was associated with a decrease in viral load (from 4.86 to 4.67 log 10 copies/mL; ). P p .009 Mortality rate. All attendees and subjects not attending follow-up who were known to be alive were censored at 6 months; those starting antiretroviral therapy (ART) were censored on the day of starting therapy. The overall mortality rate was 105.9 deaths/1000 person-years (95% confidence interval, 74.5-150.6). Table 5 shows mortality rates and rate ratios (RRs) according to helminth status at enrollment. Mortality RRs were slightly lower for subjects with hookworm or Mansonella perstans infection; these associations were not explained by age, sex, or the presence of other helminths. Schistosoma mansoni infection was associated with a slightly higher mortality rate that was not statistically significant after adjusting for age, sex, and infection with other helminths. By 12 months after enrollment (data not shown), hookworm infection was associated with a significantly lower mortality (crude RR, 0.46 [ ]; RR adjusted for age, P p .04 sex, and other helminths, 0.48 [ ]). P p .06
DISCUSSION
The present study was possible because of the existence of a large prospective cohort of HIV-infected, ART-naive patients, from a semiurban catchment area with a moderately high prevalence of helminth infection. As a result, a larger body of epidemiological data on the relationship between helminths and HIV disease progression has been collected than here in any previous studies. We have demonstrated the effects of helminth infection on CD4 + cell count, viral load, and mortality for some helminth species and shown that the impact of coinfection does not conform simply to the hypothesis of a detrimental effect on HIV disease progression.
Our use of a range of parasitological techniques has revealed a helminth prevalence of ∼50% in this cohort. Although there are important limitations inherent in determining helminth prevalence from a single stool sample [26, 27] , which might result in the misclassification of infection status, it is unlikely that there was a significant burden of undiagnosed helminth infection, for 2 reasons. First, the inclusion of the serum CAA assay avoided the potential for poor sensitivity of fecal diagnosis of Schistosoma mansoni, whether related to immunosuppression [22] or day-to-day variability in egg excretion [27] . Second, there was a strong correlation between diagnosed helminth infection and eosinophil count. The study design was based on the assumption that few subjects had received antihelminthic therapy during the 6-month period before enrollment. In fact, previous antihelminthic (but not antischistosomal) therapy was more common than we had anticipated, but the fact that it was higher among subjects with helminth infection suggests Mean changes in log 10 viral load according to helminth status at the 6-month follow-up, by helminth species at enrollment. Follow-up helminth status applies to specific helminths (where appropriate)-that is, for hookworm, subjects were classified by hookworm status at follow-up. P values refer to Student's t test comparing the mean log 10 decrease in viral load for cleared infection vs. persistent infection or reinfection, (i.e., infection absent vs. present at follow-up).
that recent therapy was not a major factor in determining helminth status at the time of enrollment. There is still the possibility, however, that the diagnostic yield was impaired in the more-immunosuppressed subjects-for example, host immunosuppression may have affected the fecundity of hookworm or adult Mansonella worms [28] . However, a small study of pregnant women from the same catchment area in Entebbe revealed no evidence of lower helminth prevalence among HIVinfected participants (A.M.E., unpublished data).
Baseline characteristics revealed a heterogeneous population with respect to sex, WHO clinical stage, tribal origin, socioeconomic status, and level of exposure to ongoing helminth infection. Of note, the level of immunosuppression (estimated by CD4 + cell count) was associated with many of these factors, with, in general, subjects of lower socioeconomic status having higher CD4 + cell counts (data not shown). One possible explanation for this is differences in health-seeking behavior, with wealthier clients accessing free health care (and therefore enrolling in the EC) at a more advanced stage of disease. Alternatively, increased mortality among poorer subjects before enrollment may have introduced some bias. However, no significant associations between socioeconomic status and prior decrease in CD4 + cell count or subsequent mortality were seen (data not shown).
The lack of association between helminth status and lower CD4 + cell count argues against the type 1/type 2 hypothesis and contradicts the results of other studies [11, [29] [30] [31] . The lack of a significant difference in CD4 + cell count decrease before enrollment may have been due to a type 1 error (the SD was greater than expected, and the number of subjects with prior CD4 + cell count data was lower than expected), but the differences seen were small in magnitude and therefore perhaps not likely to be of clinical significance.
Of interest is the significantly higher median CD4 + cell count in subjects with hookworm infection, which could not be attributed to any of the potential explanatory factors investigated. A similar association was seen for Mansonella perstans infection; however, this effect was lost after the categorization of CD4 + cell count into ‫002ע‬ cells/mm 3 for the purposes of regression analysis. A higher cutoff of 500 cells/mm 3 preserved the association ( , data not shown). P ! .04 In a predominantly HIV-negative cohort from the same catchment area and with a similar distribution of helminth species, helminths were associated with a slightly lower CD4 + cell count (A.M.E., unpublished data). This observation, in keeping with data from other HIV-negative cohorts [29] , suggests that these helminth infections per se do not result in nonspecific (or wormspecific) CD4 + expansion or redistribution. Furthermore, although the study was not designed with sufficient statistical power to detect significant differences in mortality rate according to helminth status, the observation of a lower mortality in hookworm-and Mansonella perstans-infected subjects in the current study suggests that these CD4 + cells do reflect a real immune advantage in HIV-infected subjects.
Because randomization for antihelminthic therapy was not considered to be ethical in the design of the present study, we approached the analysis of the longitudinal data by categorizing subjects into those whose infections were cleared and those with infection still present at the time of follow-up. Infection at the time of follow-up may reflect persistent infection (especially in subjects with Mansonella perstans infection, who were not given specific therapy, but probably also in many subjects with Schistosoma mansoni or Strongyloides stercoralis infection) or reinfection. This categorization is likely to mask a number of variables, including initial infection intensity and ongoing helminth exposure, which could not be explored in detail in the present study. However, changes in the eosinophil count reflected helminth status at the time of follow-up, with decreases in eosinophil counts seen only in subjects without infection at the time of follow-up and with clearance of infections, such as Mansonella species, associated with changes in immune responses (data not shown); thus, we think it is reasonable to presume that this categorization does reflect differences in the cytokine milieu between those with and without infection after antihelminthic therapy. Because all subjects received antihelminthic therapy, one would expect any benefit due to helminth infection to be lost; indeed, for all helminth species except Strongyloides stercoralis, the mean decrease in CD4 + cell count was marginally greater in those who cleared their infection than in those in whom helminths were present at the time of follow-up. However, the overall mean decrease in CD4 + cell count was similar in the helminth-free subjects, and the median CD4
+ cell count at 6 months was still higher in the hookworm-infected group, compared with the helminth-free group (315 vs. 235 cells/mm 3 ;
) . P p .11
The viral-load data provide some support for the original hypothesis, in that the mean viral load was higher among helminth-infected subjects. However, this association disappeared after adjusting for age, sex, and markers of socioeconomic status; moreover, for most helminths, there were no associations between infection status at the time of follow-up and change in viral load after antihelminthic therapy; among subjects with Mansonella perstans infection, the absence of infection at the time of follow-up was associated with a highly significant decrease in viral load.
Discordance between viral load and CD4 + cell count dynamics has been well described in response to ART and may reflect changes in lymphocyte distribution between lymphoid tissues and peripheral blood, perhaps as a result of changes in immune activation markers [32] . Alternatively, as has been seen with glucocorticoid therapy in HIV-infected subjects, inhibition of CD4 + lymphocyte apoptosis may be occurring in the presence of helminths, and the inhibition lifted after effective treatment [33] .
In conclusion, the association between helminth infection and higher viral load is largely explained by demographic and socioeconomic differences and is not reflected in lower CD4 + cell counts or higher mortality rates, compared with helminthfree subjects. Analyses of immune responses and their relationship with eosinophil count, viral load, and CD4 + cell count are under way to address these associations further. The absence of a detrimental effect of helminths on HIV progression and the suggestion that the decrease in CD4 + cell count is greater after the treatment of some worms challenges the dogma that helminths, if found, should be treated in coinfected adults. The evidence from the present study should encourage the establishment of randomized studies of antihelminthic treatment that involve, for example, immediate versus delayed antihelminthic treatment and adequate data monitoring by an independent committee, which can allow this to be done without detriment to participants. Ideally, such studies should be large enough to address the effects of different helminth species, to clarify the impact of helminths and antihelminthic treatment on HIV progression.
